ATRAAtara Biotherapeutics Inc
ATRA
Atara Biotherapeutics Inc3,659
Mkt Cap
$38.68MVolume
2.0052W High
$19.1552W Low
$3.92PE Ratio
1.77ATRA Fundamentals
Price
$5.17Prev Close
$4.73Open
$4.8650D MA
$5.08Beta
2.23Avg. Volume
459,891.51EPS (Annual)
$2.57P/B
-0.98Rev/Employee
$8.63M$274.38
Deadline Approaching: Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming May 22, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Atara Biotherapeutics...
Business Wire·17h ago
Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 22, 2026 to Discuss Your Rights - ATRA
Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 22, 2026 to Discuss Your Rights - ATRA Atara Biotherapeutics, Inc. Sued for Securities Law...
PR Newswire·20h ago
Law Offices of Frank R. Cruz Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Atara Biotherapeutics, Inc. (Atara or the Company...
Business Wire·2d ago
ATRA Shareholder Alert: May 22, 2026 Lead Plaintiff Deadline in Atara Biotherapeutics, Inc. Securities Class Action Lawsuit -- The Gross Law Firm
ATRA Shareholder Alert: May 22, 2026 Lead Plaintiff Deadline in Atara Biotherapeutics, Inc. Securities Class Action Lawsuit -- The Gross Law Firm ATRA Shareholder Alert: May 22, 2026 Lead Plaintiff...
PR Newswire·2d ago
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm EncouragesAtara Biotherapeutics, Inc. (ATRA) Shareholders To Inquire About Securities Fraud Class Action
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or...
Business Wire·3d ago
ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds...
PR Newswire·5d ago
Law Offices of Howard G. Smith Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchasedAtara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ:ATRA) securities...
Business Wire·6d ago
Securities Fraud Investigation Into Atara Biotherapeutics, Inc. (ATRA) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Atara Biotherapeutics, Inc. (Atara or the...
Business Wire·7d ago
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA Pomerantz Law Firm Announces the Filing of a Class Action Against Atara...
PR Newswire·7d ago
Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) investors concerning the Companys possible violations of...
Business Wire·7d ago
<
1
2
...
>